• Contact
  • EPAD Academy
Top Bar Menu
TwitterFacebookYouTube
Search...
EPADEPAD
EPAD
European Prevention of Alzheimer's Dementia Consortium
  • Home
  • About
    • Welcome to EPAD
    • Project Objectives
    • Project Structure
    • EPAD Partners
    • Coordination & Management
    • EPAD Q&A
  • Our research
    • Participation in EPAD
      • Participation in EPAD Cohort
      • EPAD Study Visits
      • Trial Locations
      • Participation FAQs
    • The Participant’s Experience
      • The Research Participant Panel
      • EPAD Stories
    • The EPAD platform
      • The EPAD Platform
      • EPAD Benefits
      • Clinical Candidate Selection
      • EPAD FAQs
      • Research Resources
  • Open Access Data
    • Overview
    • Access
    • Data
    • Samples
    • MRI Images
  • News & Publications
    • Latest News
    • Newsletters
    • Publications
    • Videos
Menu back  

Spotlight on Tayside

2018-11-26News

This month, we get to know the Tayside centre behind EPAD. The site began recruiting in February 2018, with its first participant enrolled on 22nd February. The team has currently recruited 50 participants and still has 6 participants due in for baselines this month, taking the total to 56 participants by the end of November. We are glad to hear that 5 (so far) research participants are booked in for December!

“We have thoroughly enjoyed running EPAD here within Tayside. The study thus far, has been no easy feat, but we enjoy a challenge”, said Kate Ferguson, the EPAD study coordinator in Tayside.

We caught up with the Tayside centre and asked them a few questions about their best practices and recruitment strategies.

Do you have any top tips to share for running the EPAD Longitudinal Cohort Study (LCS) efficiently at your site? Tayside: Building rapport with participants is key! Here in Tayside, we pride ourselves on our ability to communicate within the team and also to our participants. Right from the get go we try and establish a good rapport with potential participants, finding out as much information as possible during the screening calls. We like to take our time when recruiting participants to the study, encouraging them to ask as many questions as they want and express any concerns they may have in regards to the study (usually lumbar puncture!). Communication between the team allows us to streamline and run visits smoothly within the site.

How are you able to find suitable subjects for the cohort? Tayside: We continue to use HIC (Health Information Tracker) to recruit participants. This is a parent cohort which finds participants who have previously taken part in Generation Scotland studies. We also continue to recruit from Velocity and we find word of mouth is a wonderful thing for EPAD. The positive feedback we have had from participants, in relation to staff approach and professionalism, has been echoed in the amount of friends and family members we have recruited from participants already in EPAD.
Additionally, we use SHARE as a means of velocity recruitment and we also have access to JDR (Join Dementia Research), however we have not needed to tap into this resource at present, due to the continual flow of participants.
We are based in Ninewells hospital in Dundee and have on occasion put up a stall with study information on it and have seen a few interested individuals, one of which signed up to the study! Various members of our team attend conferences and events, handing out study information in the hopes this will boost recruitment.

Are you organising teleconferences with other EPAD sites in Scotland? Tayside: In Scotland there is usually a monthly teleconference which is held on the last Thursday of the month. We use this to discuss any issues or potential issues we have been experiencing to see if other sites can provide support and solutions. At present, Tayside, Edinburgh, Glasgow and Aberdeen are all a part of this.

“We hope to get a Tayside participant on the PPI in Edinburgh by the end of the year.” Kate Ferguson

Pictured: From left to right: Kate Ferguson (study coordinator), back left Dr Findlay (sub-I), middle Dr Gandhi (sub-I), front right Bernice Wong (back up coordinator), back right Phil Brown (administrator).
Not featured in photo:  Dr Connelly (PI), Taylor Chalmers (clinical trials support worker).

EPAD Update

We currently have 20 sites across Europe enrolling and more than 1,200 research participants screened. There was a total of 90 new research participants enrolled in the EPAD study in October. A special mention goes to Paris La Salpetriere (France) as the team screened 16 research participants in October for their inclusion in the EPAD study. We are pleased that Philip Scheltens’s team in Amsterdam (The Nerthelands) and Pablo Martinez-Lage’s team in San Sebastian (Spain) screened respectively 15 and 13 new participants in October.

Share this post
FacebookTwitterLinkedInGoogle+
Related posts
Closing EPAD article published in the Alzheimer Europe magazine
2021-02-24
Alzheimer Europe launches a report on data sharing in dementia research
2021-02-23
Local actions to keep the EPAD Longitudinal Cohort data collection going
2021-02-17
Neuronet releases its Knowledge Base dashboard
2021-02-01
The final EPAD dataset is now available to the entire research community
2020-11-30
ALZFORUM
Alzforum conference blog mentions EPAD
2020-11-30
Latest News
  • Closing EPAD article published in the Alzheimer Europe magazine
    2021-02-24
  • Alzheimer Europe launches a report on data sharing in dementia research
    2021-02-23
  • Local actions to keep the EPAD Longitudinal Cohort data collection going
    2021-02-17
  • Neuronet releases its Knowledge Base dashboard
    2021-02-01
  • The final EPAD dataset is now available to the entire research community
    2020-11-30
View the EPAD Brochure
thumbnail of EPAD brochure
Speak to the EPAD team
thumbnail of speech bubbles
Twitter
Twitter
EPAD
EPAD
@IMI_EPAD

Have a look on the @RosetreesT workshop on neurodegenerative diseases. @craig_ritchie68 presented @IMI_EPAD & @AD_PREVENT (from 1:06:00). @brainhealthscot @AlzData youtu.be/PsAZ1T5MmBo twitter.com/brainhealthsco…

reply retweet favorite
8:01 am · 2021-03-04
Twitter
EPAD
EPAD
@IMI_EPAD

The latest @AlzheimerEurope #newsletter includes an article on the first local @IMI_EPAD community meeting held last month among the Scottish research sites and collaborators who have been involved in the EPAD Longitudinal Cohort Study. Read more here: bit.ly/Feb2021AEnews twitter.com/AlzheimerEurop…

reply retweet favorite
3:26 pm · 2021-03-03
Twitter
EPAD
EPAD
@IMI_EPAD

@AD_PREVENT @alzassociation @alzheimerssoc Congratulations to all the team 👏

reply retweet favorite
7:03 am · 2021-03-01
Twitter
EPAD
EPAD
@IMI_EPAD

.@AlzheimerEurope has published a new edition of its “Dementia in Europe” magazine. It includes a closing article on @IMI_EPAD. Our co-leads @craig_ritchie68 and Serge Van der Geyten, reflect on the achievements of the project. Download the PDF here: bit.ly/DementiaInEuro… twitter.com/AlzheimerEurop…

reply retweet favorite
12:40 pm · 2021-02-24
Twitter
EPAD
EPAD
@IMI_EPAD

Last week, we held the first local @IMI_EPAD community meeting among the Scottish research sites, collaborators, academics & scientists who have been involved in our Longitudinal Cohort Study and now continue to contribute to the study locally More info⤵️ ep-ad.org/2021/02/17/loc… pic.twitter.com/MTKmanCURk

reply retweet favorite
6:51 am · 2021-02-24
Copyright © 2015-19 EPAD | Created by CMAST and Aridhia
  • Acronyms
  • Legal Notice
  • Privacy Policy
Bottom Menu

efpia-logo EU imi logo

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD grant agreement nº 115736

This website uses cookies to improve your experience. Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.